乙肝表面抗原在极端温度与pH条件下的抗原性与理化特性
本研究通过小角X射线散射、同步辐射圆二色光谱、荧光与表面等离子共振光谱及体内外效力检测,表征乙肝表面抗原(HBsAg)在pH、离子强度与温度变化下的天然状态。结果显示HBsAg对疫苗生产与储存各阶段所用pH范围高度稳定,热熔点为56°C,仅100°C才丧失疫苗效力与抗原性;6个月储存(冷藏或20°C室温)不影响稳定性,冷冻则形成大于200 nm聚集体但体内试验不受影响。
要点
- HBsAg对疫苗生产与储存所用pH范围高度稳定。
- 热熔点为56°C,但仅100°C才丧失疫苗效力与抗原性。
- 6个月冷藏或20°C室温储存不影响疫苗稳定性。
核心结论
- HBsAg在不同储存温度和极端pH值下均表现出高稳定性。
研究设计与样本
- 采用小角X射线散射、同步辐射圆二色光谱、荧光与表面等离子共振光谱及体内外效力检测联合表征HBsAg。
主要发现
- HBsAg的天然构象、形态、回转半径和抗原特性对pH处理高度稳定,尤其在生产与储存各阶段所用pH范围内。
- HBsAg热熔点为56°C,超过该点后更趋向去折叠,但仅在100°C才丧失疫苗效力与抗原特性。
- 6个月储存不影响疫苗稳定性,冷藏与20°C室温结果相似。
- 冷冻温度下形成大于200 nm的大聚集体,可能造成HBsAg含量损失,但不影响体内试验。
- HBsAg与二氧化硅SBA-15配制后二级结构含量不受影响,支持口服递送疫苗的考虑。
临床怎么用
- HBsAg疫苗生产与储存可耐受较宽pH范围,冷藏与20°C室温6个月储存均不影响稳定性。
- 应避免冷冻储存以防止形成大于200 nm聚集体及可能的HBsAg含量损失。
- HBsAg与二氧化硅SBA-15配制后结构稳定,支持口服递送疫苗的研发考虑。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hepatitis B virus causes acute and chronic infections in millions of people worldwide and, since 1982, a vaccine with 95% effectiveness has been available for immunization. The main component of the recombinant hepatitis B vaccine is the surface antigen protein (HBsAg). In this work, the effect of pH, ionic strength and temperature on the native state of the HBsAg antigen were studied by a combination of biophysical methods that included small angle X-ray scattering, synchrotron radiation circular dichroism, fluorescence and surface plasmon resonance spectroscopies, as well as in vivo and in vitro potency assays. The native conformation, morphology, radius of gyration, and antigenic properties of the HBsAg antigen demonstrate high stability to pH treatment, especially in the pH range employed in all stages of HBsAg vaccine production and storage. The HBsAg protein presents thermal melting point close to 56 °C, reaching a more unfolded state after crossing this point, but it only experiences loss of vaccine potency and antigenic properties at 100 °C. Interestingly, a 6-month storage period does not affect vaccine stability, and the results are similar when the protein is kept under refrigerated conditions or at room temperature (20 °C). At frozen temperatures, large aggregates (>200 nm) are formed and possibly cause loss of HBsAg content, but that does not affect the in vivo assay. Furthermore, HBsAg has a well-ordered secondary structure content that is not affected when the protein is formulated with silica SBA-15, targeting the oral delivery of the vaccine. The combined results from all the characterization techniques employed in this study showed the high stability of the antigen at different storage temperature and extreme values of pH. These findings are important for considering the delivery of HBsAg to the immune system via an oral vaccine.
引用
- Lopes JLS, Oliveira DCA, Utescher CLA, et al. Antigenic and physicochemical characterization of Hepatitis B surface protein under extreme temperature and pH conditions. Vaccine. 2019. PMID: 31519445. doi:10.1016/j.vaccine.2019.09.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。